Applied Materials vs. Marvell Technology: What Revenue Trends Tell Investors About These Artificial Intelligence Companies

Applied Materials reported $9.1 billion in Q2 2026 revenue, up from $7.0 billion in Q3 2024, while Marvell rose from $1.5 billion to $2.7 billion over the same comparison; Applied remained larger in all eight quarters. Marvell raised its FY2028 revenue outlook to $20 billion from $18 billion and set a FY2031 sales target of $70 billion–$90 billion, versus $8.2 billion in FY2026. The article attributes growth prospects for both companies to accelerating AI data-center and semiconductor demand.

Analysis

The revenue comparison is not an investment ranking: AMAT sells high-value tools into fab investment cycles, while MRVL sells design-led chips into networking and data infrastructure. Absolute scale therefore says little about relative earnings leverage or valuation. The more useful signal is whether AMAT’s recent acceleration reflects a sustained, broadening wafer-fab-equipment cycle or a short burst of customer spending; MRVL’s much longer-dated sales ambitions require conversion into shipped programs, not just AI demand forecasts.

Near term, the main risk is paying peak multiples for capacity plans before they translate into orders and earnings. Over 1–3 months, watch AMAT orders/guidance and semiconductor-equipment spending commentary, plus MRVL’s updates on design wins, production ramps, and customer concentration. The GlobalFoundries agreement is not evidence by itself of material GFS revenue or MRVL supply relief; verify volume, duration, and economics before trading that linkage. Over 6–18 months, fab utilization, tool lead times, export restrictions, and data-center power/build delays could interrupt the demand chain. A pullback in hyperscaler capex would hit MRVL’s AI-linked expectations first, while delayed fab projects would defer AMAT orders.

Contrarian point: the article’s AI-demand narrative treats chip demand as equivalent to realized equipment and chip revenue. Bottlenecks, customer qualification, and capex timing can widen the gap between targets and reported results. Without valuation, order, and margin data, this is not enough to justify an unconditional pair trade.

Key Decisions for Investors

• Do not trade the revenue-size comparison. Keep AMAT and MRVL on a catalyst watchlist; require company guidance and order/program evidence before adding exposure.
• Conditional 1–3 month idea: consider a modest AMAT long only if the next guidance/order update confirms broadening equipment demand, with an exit trigger on order weakness or a downward guidance revision. Do not chase a price move unsupported by estimates revisions.
• Treat MRVL’s FY2028/FY2031 targets as management aspirations, not a valuation anchor. Reassess after evidence of customer-backed ramps and shipments; a missed ramp or reduced outlook is a thesis-falsifying signal.
• Monitor GFS for disclosed capacity utilization, customer volumes, and agreement economics before expressing a GFS trade. The manufacturing agreement alone does not establish meaningful incremental earnings.